(Q34935734)
Statements
1 reference
Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil (English)
1 reference
Rodryg Ramlau
1 reference
Martin Reck
1 reference
Joachim von Pawel
1 reference
Petr Zatloukal
1 reference
Vera Gorbounova
1 reference
Vera Hirsh
1 reference
Natasha Leighl
1 reference
Jörg Mezger
1 reference
Venice Archer
1 reference
Nicola Moore
1 reference
Christian Manegold
1 reference
2 February 2009
1 reference
1 reference
27
1 reference
8
1 reference
1227-1234
1 reference
Identifiers
1 reference
1 reference